Literature DB >> 11302448

Purification of recombinant HBc antigen expressed in Escherichia coli and Pichia pastoris: comparison of size-exclusion chromatography and ultracentrifugation.

D Rolland1, M Gauthier, J M Dugua, C Fournier, L Delpech, B Watelet, O Letourneur, M Arnaud, M Jolivet.   

Abstract

Hepatitis B virus core protein (HBc) is an important serology marker of hepatitis B infection and patient follow-up. It is an M, 21,000 protein, which has the intrinsic capacity to self-assemble as a capsid-like particle. The hepatitis B core protein has been expressed in Escherichia coli and Pichia pastoris (three different constructions) in order to select a HBc recombinant antigen suitable for serodiagnosis requirements with a cost effective downstream strategy. The expression and purification of the different forms of recombinant HBc have been described. For the last step, ultracentrifugation and size-exclusion chromatography were compared. The morphology of these capsids was observed using an electron microscope. Our data shows that HBc antigen is produced in large quantities in E. coli but some contaminants remained which were associated with the E. coli HBc protein after ultracentrifugation or size-exclusion chromatography. The ultracentrifugation enables a higher purity of HBc antigen to be obtained than size-exclusion chromatography but the latter enables a higher recovery rate. P. pastoris enables the expression and extraction of a highly purified HBc antigen suitable for diagnostic purposes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11302448     DOI: 10.1016/s0378-4347(00)00538-7

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  11 in total

Review 1.  Plant-derived virus-like particles as vaccines.

Authors:  Qiang Chen; Huafang Lai
Journal:  Hum Vaccin Immunother       Date:  2012-09-20       Impact factor: 3.452

Review 2.  Norwalk virus-like particles as vaccines.

Authors:  Melissa Herbst-Kralovetz; Hugh S Mason; Qiang Chen
Journal:  Expert Rev Vaccines       Date:  2010-03       Impact factor: 5.217

3.  Bioprocessing of plant-derived virus-like particles of Norwalk virus capsid protein under current Good Manufacture Practice regulations.

Authors:  Huafang Lai; Qiang Chen
Journal:  Plant Cell Rep       Date:  2011-12-02       Impact factor: 4.570

4.  Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants.

Authors:  Qiang Chen; Junyun He; Waranyoo Phoolcharoen; Hugh S Mason
Journal:  Hum Vaccin       Date:  2011-03-01

5.  Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications.

Authors:  Arnis Strods; Velta Ose; Janis Bogans; Indulis Cielens; Gints Kalnins; Ilze Radovica; Andris Kazaks; Paul Pumpens; Regina Renhofa
Journal:  Sci Rep       Date:  2015-06-26       Impact factor: 4.379

6.  Purification of Bionanoparticles.

Authors:  L Pedro; S S Soares; G N M Ferreira
Journal:  Chem Eng Technol       Date:  2008-05-27       Impact factor: 1.728

7.  Production of the HBc Protein from Different HBV Genotypes in E. coli. Use of Reassociated HBc VLPs for Packaging of ss- and dsRNA.

Authors:  Ivars Petrovskis; Ilva Lieknina; Andris Dislers; Juris Jansons; Janis Bogans; Inara Akopjana; Jelena Zakova; Irina Sominskaya
Journal:  Microorganisms       Date:  2021-01-30

Review 8.  Hepatitis B core-based virus-like particles: A platform for vaccine development in plants.

Authors:  Maryam Moradi Vahdat; Farshad Hemmati; Abozar Ghorbani; Daria Rutkowska; Alireza Afsharifar; Mohammad Hadi Eskandari; Nahid Rezaei; Ali Niazi
Journal:  Biotechnol Rep (Amst)       Date:  2021-02-28

9.  A VLP library of C-terminally truncated Hepatitis B core proteins: correlation of RNA encapsidation with a Th1/Th2 switch in the immune responses of mice.

Authors:  Irina Sominskaya; Dace Skrastina; Ivars Petrovskis; Andris Dishlers; Ieva Berza; Maria Mihailova; Juris Jansons; Inara Akopjana; Irina Stahovska; Dzidra Dreilina; Velta Ose; Paul Pumpens
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

10.  The Hepatitis B Virus Core Variants that Expose Foreign C-Terminal Insertions on the Outer Surface of Virus-Like Particles.

Authors:  Andris Dishlers; Dace Skrastina; Regina Renhofa; Ivars Petrovskis; Velta Ose; Ilva Lieknina; Juris Jansons; Paul Pumpens; Irina Sominskaya
Journal:  Mol Biotechnol       Date:  2015-12       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.